Clinical trials: Vaccination; Series Completion

Hepatitis B

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

• Completed
• Age: 4 to 8 years
• Phase 3
• Vaccines
• Results posted

To assess the safety and immunogenicity of a booster dose of hepatitis B vaccine in children who have received a 3-dose primary series of either RECOMBIVAX HB or ENGERIX-B.

Trial name

NCT00393523

Testing

Comparator: Modified Process Hepatitis B Vaccine, Comparator: Comparator: ENGERIX-B

Volunteers

1,478 people, healthy volunteers welcome

Sponsor

Merck Sharp & Dohme LLC